G72.0 Drug-induced myopathy

Name of the Condition

• Drug-induced myopathy
• ICD Code: G72.0

Summary

Drug-induced myopathy is a condition characterized by muscle weakness or damage resulting from exposure to certain medications. It is a form of myopathy where the primary cause is identified as a drug or toxin. The condition typically involves skeletal muscle dysfunction and may present with varying degrees of weakness or pain.

Causes

The condition is caused by medications or toxins that interfere with muscle function or structure. Common culprits include statins, corticosteroids, certain antibiotics, and chemotherapy agents. The exact mechanism varies by drug but often involves mitochondrial dysfunction, inflammation, or direct muscle toxicity.

Risk Factors

• Use of medications known to cause myopathy (e.g., statins, corticosteroids).
• High doses or prolonged use of these medications.
• Pre-existing muscle disorders or metabolic conditions.
• Advanced age or renal impairment, which may affect drug metabolism.

Symptoms

• Muscle weakness, often symmetric and affecting proximal muscles.
• Muscle pain or tenderness.
• Fatigue during physical activity.
• Difficulty with tasks requiring strength (e.g., climbing stairs).

Diagnosis

Diagnosis is based on clinical history of medication use, symptom onset, and exclusion of other causes. Laboratory tests may show elevated muscle enzymes (e.g., creatine kinase). Electromyography (EMG) or muscle biopsy may be used to confirm muscle involvement, and discontinuing the suspected drug often leads to improvement.

Treatment Options

• Discontinuing or reducing the offending medication, if possible.
• Symptomatic management with pain relief or physical therapy.
• Monitoring muscle function and enzyme levels during recovery.
• Alternative medications if the original drug is essential.

Prognosis and Follow-Up

Prognosis is generally favorable with early identification and discontinuation of the causative drug. Most patients experience gradual improvement in muscle strength, though recovery may take weeks to months. Follow-up includes monitoring for recurrence and assessing residual symptoms.

Complications

• Prolonged muscle weakness affecting mobility.
• Secondary complications from immobility (e.g., falls, contractures).
• Rarely, severe cases may lead to respiratory muscle involvement.

Lifestyle & Prevention

• Avoiding or minimizing use of high-risk medications when alternatives exist.
• Regular monitoring of muscle symptoms during long-term drug therapy.
• Maintaining overall muscle health through exercise and nutrition.

When to Seek Professional Help

Seek medical attention if you experience new or worsening muscle weakness, pain, or fatigue, especially after starting a new medication. Prompt evaluation can prevent progression and guide appropriate management.

Tips for Medical Coders

Document the specific drug or toxin responsible for the myopathy, as this is critical for accurate coding. Ensure the clinical record supports the temporal relationship between drug exposure and symptom onset. Include details on medication history, dose, and duration to justify the diagnosis.